Výsledky vyhledávání - "Fleur M, van der Valk"

Akademický článek

Current therapies for lowering lipoprotein (a)

Autor: Julian C. van Capelleveen, Fleur M. van der Valk, ErikS.G. Stroes

Publikováno v: Journal of Lipid Research, Vol 57, Iss 9, Pp 1612-1618 (2016)

Lipoprotein (a) [Lp(a)] is a human plasma lipoprotein with unique structural and functional characteristics. Lp(a) is an assembly of two components: a central core with apoB and an additional glycoprotein, called apo(a). Ever since the strong associa

Externí odkaz: https://doaj.org/article/cfd332c59ef84ecdba3093b30a155a2d

Zobrazit plný text záznamu

Confused about Confusion

Autor: Anne M. Spanjaart, Fleur M. van der Valk, Geeske van Rooijen, Matthijs C. Brouwer, Marie J. Kersten

Publikováno v: New England Journal of Medicine, 386(1), 80-87. Massachussetts Medical Society
New England journal of medicine, 386(1), 80-87. Massachussetts Medical Society
Spanjaart, A M, van der Valk, F M, van Rooijen, G, Brouwer, M C & Kersten, M J 2022, ' Confused about Confusion ', New England Journal of Medicine, vol. 386, no. 1, pp. 80-87 . https://doi.org/10.1056/NEJMcps2114818

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35d8c5905710f18c7410420c3a2e239a
https://doi.org/10.1056/nejmcps2114818

Zobrazit plný text záznamu

Akademický článek

Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA[S]

Autor: Ruud S. Kootte, Loek P. Smits, Fleur M. van der Valk, Jean-Louis Dasseux, Constance H. Keyserling, Ronald Barbaras, John F. Paolini, Raul D. Santos, Theo H. van Dijk, Geesje M. Dallinga-van Thie, Aart J. Nederveen, WillemJ.M. Mulder, G.Kees Hovingh, JohnJ.P. Kastelein, Albert K. Groen, ErikS. Stroes

Publikováno v: Journal of Lipid Research, Vol 56, Iss 3, Pp 703-712 (2015)

Reverse cholesterol transport (RCT) contributes to the anti-atherogenic effects of HDL. Patients with the orphan disease, familial hypoalphalipoproteinemia (FHA), are characterized by decreased tissue cholesterol removal and an increased atherogenic

Externí odkaz: https://doaj.org/article/0198d50b673d41dea68fe895d4ff2269

Zobrazit plný text záznamu

PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia

Autor: Johan G. Schnitzler, Fleur M. van der Valk, Jan Van den Bossche, Menno P.J. de Winther, Erik S.G. Stroes, Garen Manvelian, Renate M. Hoogeveen, Jeffrey Kroon, Annette E. Neele, Marten A. Hoeksema, Marie T. Baccara-Dinet, Sophie J. Bernelot Moens

Publikováno v: Bernelot Moens, S J, Neele, A E, Kroon, J, Van Der Valk, F M, Van Den Bossche, J, Hoeksema, M A, Hoogeveen, R M, Schnitzler, J G, Baccara-Dinet, M T, Manvelian, G, De Winther, M P J & Stroes, E S G 2017, ' PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia ', European Heart Journal, vol. 38, no. 20, pp. 1584-1593 . https://doi.org/10.1093/eurheartj/ehx002
European Heart Journal, 38(20), 1584-1593. Oxford University Press
European Heart Journal
European heart journal, 38(20), 1584-1593. Oxford University Press

Aims Migration of monocytes into the arterial wall contributes to arterial inflammation and atherosclerosis progression. Since elevated low-density lipoprotein cholesterol (LDL-C) levels have been associated with activation of plasma monocytes, inten

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::711da210bfa4ae04040b981da9111c1a
http://www.mendeley.com/research/pcsk9-monoclonal-antibodies-reverse-proinflammatory-profile-monocytes-familial-hypercholesterolaemia

Zobrazit plný text záznamu

Thresholds for Arterial Wall Inflammation Quantified by 18F-FDG PET Imaging

Autor: Fleur M, van der Valk, Simone L, Verweij, Koos A H, Zwinderman, Aart C, Strang, Yannick, Kaiser, Henk A, Marquering, Aart J, Nederveen, Erik S G, Stroes, Hein J, Verberne, James H F, Rudd

Publikováno v: Jacc. Cardiovascular Imaging

Objectives This study assessed 5 frequently applied arterial 18fluorodeoxyglucose (18F-FDG) uptake metrics in healthy control subjects, those with risk factors and patients with cardiovascular disease (CVD), to derive uptake thresholds in each subjec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e450d794c185b9455139cbcc20215720

Zobrazit plný text záznamu

Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA

Autor: Raul D. Santos, Theo H. van Dijk, Erik S.G. Stroes, Loek P. Smits, Fleur M. van der Valk, John F. Paolini, Geesje M. Dallinga-van Thie, Aart J. Nederveen, Ruud S. Kootte, Albert K. Groen, Willem J. M. Mulder, G. Kees Hovingh, John J.P. Kastelein, Constance Keyserling, Ronald Barbaras, Jean-Louis Dasseux

Publikováno v: Journal of Lipid Research, 56(3), 703-712. AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
Journal of lipid research, 56(3), 703-712. American Society for Biochemistry and Molecular Biology Inc.
Journal of Lipid Research, Vol 56, Iss 3, Pp 703-712 (2015)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69939042d1b1972246343ab07733bd59
https://doi.org/10.1194/jlr.m055665

Zobrazit plný text záznamu

Novel directions in inflammation as a therapeutic target in atherosclerosis

Autor: Fleur M. van der Valk, Erik S.G. Stroes, Simone L. Verweij

Publikováno v: Current opinion in lipidology. 26(6):580-585

Atherosclerosis is a chronic disease of the arterial wall largely driven by inflammation; hence, therapeutics targeting inflammatory pathways are considered an attractive strategy in atherosclerotic cardiovascular disease (ASCVD). The purpose of this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a6d1eee7fa64cd2144840fb6b19665d
https://doi.org/10.1097/mol.0000000000000233

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání